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The object of this study was to assess the status of the cellular
immune response in the year-old weak calf runt, as well as the
therapeutic benefits of thymosin, a protein thymic extract shown
capable of inducing the maturation of thymus-derived lymphocytes.
Various assays currently available for evaluating the cellular
component of the immune response, such as delayed hypersensitivity,
lymphocyte proliferation, lymphokine production and humoral
response to thymus-dependent antigens, were conducted. The
results of these tests indicated no immunological abnormalities
or deficiencies in weak calf responses when compared to the
responses of normal calves, other than a minor depression in
delayed hypersensitivity0
The ability of thymosin to correct the deficiency in delayed
hypersensitivity and to promote normal growth and development in
the weak calf was examined, rfeak calves received 3^,000 jug of
thymosin a month for a period of four months and during this time
their weights were monitored as well as their response to the
tuberculin skin test antigen. After the four months, no
discernible improvement in the weak calves receiving the thymus
extract was observed that was not observed in the control animals,
while the difference in delayed tuberculin hypersensitivity
responses in thymosin treated animals were no longer significantly
different from the responses of the normal animals, inconsistencies
in the test results made it impossible to attribute this change
to thymosin therapy.
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Chapter 1
INTRODUCTION

The V/eak Calf Syndrome
Investigations into severe calf losses in the Bitterroot Valley of Montana in 1964 led to the recognition of a
new disease condition of neonatal cattle (41). Because the
calves afflicted with this disease appeared weak at birth
and unable to rise, this condition became known as the
V/eak Calf Syndrome (WC3). In recent years, WCS has become
a prevalent problem in parts of the Western United States
and Canada and has resulted in significant economic losses
to ranchers due to late abortion and a high mortality of
calves less than six weeks of age (52). Mortality rates
have been reported to be as high as 80>5 in affected herds (10).
Of depressing consequence of the disease condition is that
a high number of calves surviving the afflection fail to
exhibit normal growth and develop into runted animals.
At or within the first few weeks after birth, weaksyndrome calves exhibit a depression along with a reluctance
to stand, move or even nurse. Polyarthritis, a crusting and
reddening of the muzzle and lips and calf scours are also
observed.

These calves exhibit a marked leukopenia at birth

averaging 1 x 10^ WBC/mm^ in comparison to 2.2 x 10^ VvBC/rnm^
1

for normal calves (56).

The leukopenia is transitory and

shifts to a leukocytosis about four days later.

Histopath-

ology of the weak calf is characterized by subcutaneous
bilateral edema and hemorrhages of the extremities, hemor
rhages on the third eyelid, tongue, esophagus and trachea,
involution of the thymus, enlargement and edema of the lymph
nodes, petechial hemorrhages of internal organs, polyarthritis
and synovitis (10, 65).
Early treatment of weak calves with intravenous injec
tions of electrolyte solutions and transfusions of whole
blood or the administration of immune sera proved beneficial
for those calves less severely afflicted, but this did not
alter the course of the runting syndrome associated with
the disease.

Later, thymosin, a protein thymic extract,

was used in the treatment of weak calves (64).

Again those

calves less severely afflicted showed an improvement in
health but no subsequent return to normal weight.
A depression in cellular immune responsiveness has been
observed in weak calves

skin tested with tubercle bacilli.

V/eak syndrome calves sensitized with Mycobacterium bovis,
Paris strain bacille Calmette Guerin (BCG), failed to mount
a delayed hypersensitivity response to the BOG skin test
antigen (56).

Other studies have shown that lymphocytes

from newborn weak calves responded to a lesser degree than
lymphocytes from newborn normal calves when stimulated with
phytohemagglutinin (PHA), a non-specific I-lymphocyte
mitogen (64).
2

Hunting Syndrome
The induction of a runting syndrome is observed in
laboratory animals after various experimental procedures.
These procedures are carried out during the neonatal period
and include thymectomy (35), administration of cortisone
acetate (25) or sterile bacterial vaccines (13), the in
jection of foreign immunologically competent cells (5) and
infection with certain viruses (54, 57).

The resulting

syndrome is usually defined by the following characteristics:
1) loss of body weight to less than 60;S, 2) clinical symp
toms such as lethargy, periorbital edema, ruffled fur,
lymphocytopenia, diarrhea and atrophy of the thymus and
other lymphoid organs, 3) subsequent early death (54).
Examination of organs of runted animals at autopsy
shows many organs to be of subnormal size due to the deple
tion in the number of normal parenchymal cells within the
organs (39> 40).

This organ abnormality can be differen

tiated from those occurring during malnutrition which
results in a decreased cytoplasmic volume and not in the
number of parenchymal cells (33). In addition, a significant
depletion of lymphocytes is observed in the lymphoid organs.
The thymus of the runted animals lacks any histological
resemblance to a normal thymus (57). The cortex is reduced
to a thin perimeter of lymphocytes and the medula is re
placed with histiocytes.

This histological pattern is also

observed in the enlarged lymph nodes of the runts.

A

leukocytosis due to an increase in the granulocyte population
3

is also present (57). The normal ratio of lymphocytes to
granulocytes is completely reversed with 70-80/5 granulocytes
observed in the differential count.
The etiology of this runting syndrome has not been
completely clarified and more than one mechanism may con
tribute to the growth disorder of the various runts.

Micro

organisms appear to play some role in thymectoraized and
Cortisone-induced runting in mice.

On the other hand,

axenic animals do not develop the runting syndrome after
thymectomy and appear to have an increased resistance to
runting induced by cortisone administration (43).

Anti

biotics reduce the severity of wasting that occurs following
both types of treatment but not the runting caused by
sterile bacterial vaccines (2).
Immunologic mechanisms also appear to play a role in
runting syndromes.

Runting due to the injection of foreign

immunologically competent cells is believed to result from
the immunological response of the donor cells against the
transplantation antigens of the host (54).
Viral-induced minting may be due to the immunological
destruction of lymphatic cells that acquire viral antigens
as well as the direct cytopathic effect of the virus on
lymphatic cells and its inhibitory effect on cell multi
plication (54).

Growth retardation has also been reported

in human infants with congenital rubella (38) and cytomegalo
virus infections (40).

A subnormal number of parenchymal

cells is also observed in many organs of these infants as
4

well as a decrease in lymphoid elements.

Surviving infants

are unable to mount any humoral response to these viruses
until approximately one to two years of age.

Cellular Immunity
The immune response of an organism to a foreign antigen
can manifest itself in two ways:

the production of humoral

antibody and/or the development of cellular immunity.
Although the two responses are not entirely independent,
the two mechanisms are distinctly different.
The study of cellular immunity began with the investi
gations of Landsteiner and Chase (33) in 1342.

Their

experiments showed that delaj^ed hypersensitivity could be
transferred to unsensitized hosts by lymphoid cells but not
by serum from sensitized individuals.

The delayed hyper

sensitivity reaction is an immunologically specific response
occurring in appropriately sensitized animals after reintroduction of the antigen.

The reaction occurs several

hours after reinfection of the antigen and is characterized
by increasing erythema and induration at the site of injec
tion.

The erythema and induration are the result of an

infiltration of predominantly mononuclear lymphocytes and
mononuclear phagocytes (33).
It is now recognized that cell-mediated mechanisms are
responsible for certain immune responses to a variety of
antigens including viral, microbial, heterologous protein
antigens, transplantation antigens (organ and skin grafts)
5

and autologous antigens (autoimmune disease)(33).
Of the two classes of lymphocytes known today, thymusderived lymphocytes (T-lymphocytes) and bone marrow-derived
lymphocytes (3-lymphocytes), it is the T-lymphocytes that
are involved in these cell-mediated immune mechanisms
(33, 45)#

Enumeration of B-lymphocytes and T-lymphocytes

can be accomplished based on their differing surface struc
tures.

B-lymphocytes have easily detectable membrane immuno

globulins as well as receptors for complement and the Fc
region of IgC, all of which serve as population markers (25).
These markers are absent from T-lymphocytes, which are
recognised by their formation of spontaneous rosettes with
sheep erythrocytes (B-rosettes).

The formation of E-rosettes

is non-immunological but serves as a convenient marker of
T-lymphocytes.

These lymphocytes have been identified as

thymus-derived lymphocytes by virtue of the inhibition of
rosette forma/tion by anti-theta serum, anti-lymphocyte serum
and asathioprine, but not by anti-immunoglobulin (3, 12).
E-rosettes have also been reported to serve as a
marker for bovine T-lymphocytes (13).

The number of bovine

peripheral blood lymphocytes (PBL) has been reported in the
literature to range from 0/s (20) to 19',^ (18) with assay
parameters varying from study to study.

It appears that

while all human and mouse T-lymphocytes form E-rosettes,
only a subpopulation of bovine T-lymphocytes form E-rosettes (18)
In vivo and in vitro assays based on the immune func
tions of T-lymphocytes are currently being used to evaluate
6

cellular immunity.

Delayed hypersensitivity skin testing

is probably considered the most reliable in vivo procedure
for the evaluation of cellular immune responsiveness.
The development of a delayed hypersensitivity reaction at
the site of injection of the skin test antigen indicates
that the afferent, central and efferent portions of the
immune response are functioning normally and that the
ability to mount a non-specific inflammatory response is
intact (51).
The migration inhibition test, an in vitro assay shown
to correlate with in vivo delayed hypersensitivity, is often
used in human medicine. V/hen sensitised lymphocytes are
stimulated in vitro by the sensitizing antigen, a soluble
factor called migration inhibition factor (HIP) which
retards the migration of macrophages and leukocytes from
capillary tubes is produced.

The production of MIF in

response to the specific antigen gives an evaluation of
lymphocyte function as it relates to cellular delayed
hypersensitivity (44).
In vitro lymphocyte proliferative responses (blastogenesis) are also used to evaluate cellular immunity.

The

induction of blast-like transformation of sensitized
lymphocytes by the sensitising antigen can be quantified by
measuring the incorporation of tritiated thymidine into
newly synthesized DNA.

Certain plant mitogens can also

induce lymphocyte proliferation by reacting non-specifically
with the cell surface and instigating the same series of
7

cellular events.

Phytohemagglutinin (PHA) is one such plant

mitogen, but unlike antigen stimulated proliferation where
only a small fraction of the lymphocytes are sensitive,
PHA induces blastogenic activity non-specifically in the
majority of the ?—lymphocytes (45).

Immunosuppression by Corticosteroids and Viruses
Cellular immune responsiveness can be depressed nonspecifically by a variety of factors such as neoplastic and
infectious diseases, trauma, X-irradiation, malnutrition
and elevated corticosteroid levels (54).
Corticosteroids are commonly used as chemotherapeutic
agents for the suppression of undesirable immune and
inflammatory responses.

Although the precise mechanism

of action is unknown, these steroids appear to act on many
aspects of the immune response, from the inhibition of skin
allograft rejection in mice to the inhibition of tuberculin
skin test reactivity in man (7, 15).
The effect of corticosteroids upon circulating lymphoid
cells has been described by Fauci and Dale (14). A transient
lymphopenia with decreases in circulating lymphocytes and
monocytes is observed after a single intravenous dose of
hydrocortisone.

The depletion of lymphocytes is selective

with a proportionately greater decrease in the number of
'T-lymphocytes as measured by the E-rosette assay.

This

decrease in circulating lymphoid cells is believed to be
due to redistribution to other body compartments from the
3

circulation rather than by direct destruction.
A decrease in antigen responsiveness in vitro is observed
after hydroxycortisone administration (14).

This decrease

correlates well with the suppression of delayed hypersen
sitivity that occurs during corticosteroid therapy.

Migration

inhibition factor activity is also suppressed significantly
by corticosteroids (4), which appear to disrupt inhibitory
effect of MIF on the macrophage as opposed to antigen pro
cessing by the macrophage or the ability of lymphocytes to
produce MIF.
Immunosuppressive effects of corticosteroids are of
interest in studying immunosuppression in the weak calf due
to the high levels of corticoids in newborn calves. Plasma
corticoid levels in neonatal calves are extremely high,
averaging 116.4 ng/ml at parturition and falling to a level
of 2.2 ng/ml by day ten (22). Corticoid levels in calves
with infectious calf diarrhea are generally higher than in
healthy calves of the same age.

Levels during the first

four days of life are double that of healthy calves.

Eight

to 25/U of calves with infectious calf diarrhea die before
the a,ge of two months, and many of those that survive are
permanently sttinted (22).
The ability of many viruses to suppress cellular
immunity during and after infection has been demonstrated
in various studies.

In 1908 von Pirquet (63) reported

suppression of tuberculin delayed hypersensitivity in
children with measles, all of which had previously been
q

skin test positive.

In 1919, Bloomfield and Mateer (63)

reported the same suppression in patients with acute
influenza infections.

Many viruses known to suppress

cellular immune responsiveness have since been added to
the list.

Mumps, rubella, Newcastle disease virus and

poliovirus are among those shown to inhibit the in vitro
response of normal lymphocytes to PHA while infants with
congenital rubella infections also have a depressed lympho
cyte response to PHA (26). This suppression of T-lymphocyte
function may be the result of histological changes in thymic
and other lymphoid tissue that has been observed in acute
measles infections (63).
Perhaps the most noteworthy observation in suppression
of cell-mediated immunity induced by viruses are those changes
effected by mouse thymic virus (MTV). Neonatal infection of
mice with MTV, a herpesvirus, results in thymic necrosis and
cellular depletion.

Inoculation of newborn mice with MTV

results in a syndrome resembling neonatal thymectomy and
results in functional T-lymphocyte depletion (8).

Thymic Immunodeficiencies
Besides the non-specific immunosuppressing factors
mentioned, immune responsiveness can also be suppressed by
primary immunodeficiency diseases.

Immunodeficiency diseases

result from defects in the development of normal immune
responses where either the ability to produce antibodies
and/or the development of cell-mediated immunity is depressed
10

or absent.

Over thirty discrete phenotypic patterns of

immunodeficiency have been described in man (9)»

Although

classification of many of the clinical symptoms is difficult,
distinct patterns have been recognized enabling the general
classification of defects into three categories based on
cellular response: 1) B-lymphocyte, 2) T-lymphocyte and stem
cell deficiencies.

Only T-lymphocyte deficiencies will be

discussed in this thesis.
The role of the thymus in the development of immunity
was first suggested by the frequent occurrences of thymic
abnormalities in children with immunological deficiency
disorders.

The thymus is a lymphoid organ comprised of

lymphoid and epithelial cells.

During embryogenesis, the

thymus along with the parathyroid gland arises from the
third and fourth pharyngeal pouch epithelium and in most
species is fully developed by birth (23).

The thymus exerts

its influence on precursor bone marrow stem cells.

These

cells differentiate into immunocompetent T-lymphocytes in
the thymus and are transported from the thymus to peripheral
lymphoid tissues, blood and lymph (62). Failure of the
thymus to develop properly results in thymic immunodeficiency,
under which conditions precursor stem cells fail to dif
ferentiate into T-lymphocytes responsible for cellular
immunity.
Congenital thymic aplasia in man, known as Di George's
Syndrome, occurs when the thymus fails to arise during the
sixth week of embryonic life.
11

Cause for this embryonic flaw

is still unknown.

Autopsy reveals little or no thymus and

parathyroid tissues, and those infants surviving exhibit
a high susceptibility to viral, fungal and bacterial in
fections. In thymic aplasia, germinal center development
and immunoglobulin synthesis remain normal, but the depletion
of lymphocytes in the subcortical, thymus-dependent regions
of the lymph nodes as well as the lymphoid sheaths of the
spleen are prominent (46). Deficiencies in cellular immunity
such as the loss of delayed hypersensitivity to common anti
gens, loss of ability for skin graft rejection, lowered
response of peripheral blood lymphocytes to mitogens have
been observed.

Transplants of fetal thymus tissue have

been successful in correcting the deficit of T-lymphocytes
and cellular immunity in Di George's Syndrome patients.
Normal skin graft rejection, response to intradermal skin
test antigens, in vitro response to mitogens as well as
increased lymphocyte count and population of thymus-dependent
areas are observed as early as 48 hours after the
transplant (46).
Congenital thymic dysplasia, or Nezelof Syndrome, is
a genetically acquired thymic immunodeficiency in contrast
to Di George's Syndrome which has no genetic involvement.
In this autosomal recessive disease, the thymus is reduced
in size, consists almost entirely of epithelial cells and
lacks any Hassall's corpuscles.

While the population of

circulating ljnnphocytes is not depleted and immunoglobulin
levels usually appear normal, cellular immune responsiveness
12

is impaired (9). In thymic dysplasia,, -transplantation of
fetal thymus tissues does not correct the T-lymphocyte
deficiency.

An abnormality in the inductive function of

the epithelial portion of the thymus is believed to be
responsible for the immunologic deficiency (9).
While the preceding are examples of blatant, primary
thymic immunodeficiencies, persons with chronic mucocutaneous
candidiasis s erve as examples of more subtle T-lymphocyte
deficiency.

In these cases the circulating population of

T—lymphocytes is normal as well as their in vitro pro
liferative responses to mitogens, but the expression of
delayed hypersensitivity and lymphokine production is
impaired (9).

Effects of Thymectomy
Thymectomy has been used as a laboratory procedure to
induce artificially a thymic immunodeficient condition in
laboratory animals.

While the effects of thymectomy in adult

animals are slight, thymectomy during the neonatal period
produces a severe depletion of the T-lymphocyte population,
defects in the development of immune functions and gross
changes in the histology of lymphoid tissue (34, 46).
The most notable result of thymectomy is the associated
wasting disease characterised by decreased growth rate, list—
lessness, ruffled fur, hunched posture, periorbital edema,
diarrhea and death (23, 36). The cause of the wasting disease
has been attributed to the animals1 increased susceptibility
13

to infectious diseases due to on inability to respond immuno
logically to pathogenic organisms.

Thymectomized animals

given either antibiotics or kept in germ-free environments
exhibit a reduction or no change in the incidence of wasting
or none at all.
Many of the immunological consequences of neonatal
thymectomy are similar to those observed in congenital thymic
aplasia.

Thymectorn;,'- results in a reduction in the population

of circulating lymphocytes (the immunologically competent
cells responsible for cell mediated immunity) and depletion
of thymus-dependent areas of the lymph nodes and spleen.
Among the serious defects in cell-mediated immune responses
observed are impairment of homograft rejection, inability
to elicit delayed hypersensitivity reactions to tubercle
bacilli and bovine serum o-lbumin and e, reduced humoral re
sponse to certain antigens (i.e. sheep erythrocytes, human
gajvima globulin and ova albumin) (36).

Thymic Reconstitution
Thymic deficiencies have been treated by a variety of
procedures.

As mentioned earlier, reconstitution of patients

with congenital thymic aplasia using grafts of fetal thymus
tissue has resulted in restoration of immunological competence.
Restoration of immunological competence in neonatally thymectomized mice using lymphoid cell suspensions or thymic
grafts have also been successful (36).

I.lore interacting are the implantation studies using
cell-tight Millipore diffusion chambers containing thymus
tissue into peritoneal cavities of young thymectomized mice.
These chambers permit large size molecular exchange (pore
size approximately 0.1 jum in diameter) but restrict the
passage of cells.

Restoration of skin graft rejection and

humoral antibody response to sheep erythrocytes and human
gamma globulin have been observed in a majority of these
animals.

Circulating lymphocytes are only r:iodera,tely reduced

in number, and the spleen and lymph nodes are almost normal
in size and cellular content (31, 40).
These studies suggest tha/fc thymic tissue produces a
specific humoral factor that triggers differentiation and
maturation of lymphoid precursor cells to immunologic com
petence.

Examinations of the tissue within the diffusion

chambers several vreeks after their implantation shov/s only
epithelial cells to be present.

These findings suggest that

the epithelial cells of the thymus are responsible for pro
duction of the humoral substance (53)•
r.Iore recently, interest has centered around the use of
thymus cell-free extracts.

A thymic factor called thymosin

has been isolated from calf thymus tissue and has been shov/n
to be involved in the development and maturation of lymphoid
tissue by a variety of in vivo and in vitro studies (16,55).
Thymosin treatment of neonatally thymectomized mice has been
shorn to induce immunological competence.
15

In these mice,

thymosin treatment has significantly reduced the incidence
of wasting disease while increasing the number of circulating
lymphocytes and conferring a partial restoration of cellular
immunity as measured by homograft rejection (1).
Thymosin treatment 1ms also been applied to human
patients with thymic hypoplasia and has resulted in improved
clinical appearance, the appearance of a previously depressed
delayed hypersensitivity and an increased percentage of
in vitro T-lymphocyte E-rosettes (60).

Action of Thymic Hormones
Restoration of lymphocyte activity to azothioprine,
anti-lymphocyte serum and anti-theta serum in neonatally
thymectomized mice by thymic hormones has been taken as an
indication of its ability to induce immuiiocompetence in
thymus-dependent lymphocytes (3, 16). This activity of
thymic hormones on I-lymphocytes has been supported by the
ability of thymic hormones to induce in vitro development
of characteristic T-lymphocyte stirface antigens TL, Thy—1
and Ly from populations of spleen and bone marrow cells of
adult mice (27)• 'The presence of any one of these markers
indicates that the cell has undergone thymus-directed
differentiation. Cells from spleen and bone marrow of nu/nu
mice can also bo induced to develop T-lymphocyte surface
antigens. Since nu/nu mice are congenitally thymus deficient,
the inducible cell must be a precursor coll that has not
16

undergone any thymus-directed process (26, 32).
How thymic hormones induce immunocompetence is not fully
understood.

Experiments monitoring activation of membrane-

associated enzymes in lymphoid cells exposed to thymic
hormones indicate that they exert their influence by activating
membrane-associated adenyl cyclase which leads to a rise in
intracellular cAKP (1). This elevation of membrane-associated
enzyme activity is only observed in thymus-derived cells.
It has been suggested that these hormones act on at
least three distinct classes of lymphoid cells: pre—thymic
stem cells, thymus-derived cells (Tq and T^ cells) and mature
T—lymphocytes (Tg cells) (55). Thymic hormones appear to
function by accelerating the development and maturation of
stem cells into immunologically competent lymphocytes arid
then function in their further differentiation into special
ized T-lymphocytes such as memory, killer, suppressor or
effector lymphocytes.

Statement of Thesis
weak Calf Syndrome has become a problem in the cattle
industry resulting in significant economic loss to the cattle
rancher.

The possibility of thymic dysfunction in these

animals is suggested by the absence of a, normal thymus,
runted appearance and 'failure to respond normally to tuber
culin skin test antigens.

17

Treatment with thymic extracts in other thymic deficient
systems has been shown to induce immunological competence.
Applicability of treatment with thymic extracts has been
demonstrated in newborn weak calves as judged by significant
improvement in health and increase in uptake of tritiatedthymidine upon stimulation of lymphocytes with the T-lympho—
cyte mitogen PIIA in an in vitro system (64).
The purpose of this study was designed to: 1) evaluate
the status of the immune system of the weak calf by measure
ment of various immunologic parameters and 2) investigate
the effects of treatment with thymosin, a protein thymic
extract, on those parameters and on the general overall
appearance of the weak calf.
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Chapter 2
MATERIALS AND METHODS

Animalo
Calves used in this study were made available through
a loan obtained from Mr, Duane Van Meter, a cattle rancher
in the Bitterroot Valley of Montana.

All calves were approx

imately one year of age at the start of this research, pro
ject.

These calves were classified as either normal or weak

calves by Dr. Jack Ward, a practicing veterinarian in
Hamilton, Montana, who first recognised the weak calf problem
in 1964. The criteria used in the classification of the
calves were:

comparative sise for year-old calves, growth

rate and hair coat texture (illustration 1).

An attempt was

made to utilise in this study calves believed to have been
afflicted with varied degrees and intensities of the disease
condition.

Collection of Samples
Blood samples v/ere collected from animals by Dr. Ward.
Forty ml of venous blood was drawn by venipuncture from the
jugular vein.

Twenty ml was transferred to vacutainer

collection tubes for the collection of serum and to tubes
containing 1,000 units of preservative-free sodium heparin
19

Illustration 1.

The comparative size difference of year-

old. normal and weak calves is illustrated in the following
photograph.

Other physical characteristics of the weak

calf, such as rough coat texture and periorbital edema,
can also be observed.
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(Lilly) for whole blood samplea.

All samples were kept at

ambient temperature during transport from Hamilton to the
laboratory and were processed immediately upon arrival.

Differential White Blood Cell Counts
Blood smears were prepared from heparinized whole blood
and stained with Wright's stain (Medi Chemicals Inc.) for
differential V.BC counts (Table 1).

After staining, the blood

smears were examined under oil and a total of 200 cells were
counted.

Cell types were identified as lymphocytes, mono

cytes, eosinophilic granulocytes, basiophilic granulocytes
and segmented and juvenile neutrophilic granulocytes.

Table 1

'.'.'right's staining procedure.

1) Fix blood smear in absolute methanol for 1 second.
2) Place slide in Wright's stain #1 (eosinate stain)
for 20 seconds.
3) Wash slide in distilled water.
4) Place slide in Wright's stain
for 20 seconds.

i-2

(polychrome stain)

5) Wash slide in distilled water and air dry.

Total White Blood Cell Counts
Using WBC diluting pipettes, heparinised whole blood was
diluted 1:20 with Turk's diluting fluid (Table 2) for total
leukocyte counts.
meters.

Counting was done in Neubauer hemocyto-

All four corner mm^ squares wore counted and the

total leukocyte count was calculated using the following
formula.:
number of leukocytes counted x dilution x 10
number of mnP squares counted
leukocytes/mm

Table 2

*3

Turk's white blood cell diluting fluid.

Glacial acetic acid . . . . .

2 ml

Aqueous gentian violet

1 ml

Distilled -atcr

100 ml

Mix and filter sterilize.

Ficoll-diatrizoate Separation of Peripheral Blood Leukocytes(PBL)
Separation of PBL on ficoll-diatrizoate density gradients
was conducted by the method of Boyum (6). Twenty ml of
heparinized bovine blood was centrifuged in 40 ml conical
centrifuge tubes at 650 x g for 30 min at 4°C.

The buffy

coat was removed and resuspended in Hank's BSS and carefully
layered over 5 ml of ficoll-diatrisoate (Table 3) in a 15 ml
conical centrifugc tube.

The blood-ficoll gradient was spun

at 400 x g for 20 min at 4°C.

The cells at the ficoll and

Hank's interface were harvested and washed in Hank*a BSS.
The leukocyte pellet was resuspended and incubated in 0.830
NH^Cl for 5 min to remove contaminating red blood cells.
The leukocytes were washed two additional times in Hank's
BSS and resuspended in tissue culture media.

Table 3

Ficoll-diatrisoate

1) Dissolve 9.63 g sodium diatrisoate (T.'inthrop Labs.)
in 30 ml of distilled water and adjust the pH to 7*3.
2) Add 72 ml of distilled water.
3) Dissolve 6.35 g ficoll (Pharmacia) in the above solution.
4) Heat sterilise at 121°C for 15 min. Store at 4°C in
a foil covered bottle to prevent exposure to light.

Blastogenesis
Leukocytes separated via ficoll-diatrizoate were adjusted
to a concentration of 1 x 10 6 cells/ml in 10 ml of RPMI media
with 100 PCS (Table 4). Triplicate 1 ml samples were removed
and placed in glass tissue culture tubes and labeled "control
cultures."

After discarding 2 ml, 0.05 ml of a stock PHA-P

solution (Table 5) was added to the remaining 5 ml of the
cell suspension to achieve a final PHA-P concentration of
1 jil/ral.

Triplicate 1 ml samples were removed and placed

in glass tissue culture tubes and labeled "PHA-P cultures."
All cultures were incubated at 37°C in 50 COg.
After 72 hrs, the cultures were removed from the in
cubator, and 0.1 ml of a stock tritiated thymidine solution
(Table 6) was added to each tube to achieve a final concen
tration of 1 juCi/ml.

The cultures were returned to the

incuba/fcor for an additional 24 hrs.
After a total of 96 hrs of incubation, the cultures were
processed for counting by liquid scintillation using a
Nillipore sampling manifold.

Using suction, cells 'were

collected on damp Whatman GF/C filter paper and washed with
24

Table 4

RPMI 1640 media

RPMI 1640 dry powder (Gibco) . . . .
Triple distilled water

..

1.0 liter

Penicillin G

100,000 units

Streptomycin sulfate

100,000 p.g

Petal calf serum (l.Iicrobiology Associates)
inactivated at 56 C for 30 min .... 100 ml

Table 5

Phytoliemagglutinin-P (PHA-P) stock solution.

PHA-P (Difco)

1 ml

RPMI 1640 media with 10^ PCS

9 ml

Stock PHA-P solution was stored in 0.05 ml calibrated
dropper bottles at - 70°C until used. Pinal concentration
of tiie PHA-P stock solution is 5 J.I1/IV2.,
L

Table 6

Tritiated thymidine stock solution.
\

Thymidine, raethyl-JH. 1 mCi, specific activity
71.5 Ci/mmole (ICIT)
1 ml
RPKI 1640 media with 10'/$ PCS

99 ml

Pinal concentration of the tritiated thymidine stock
solution is 10 ^iCi/ml. Stock solution was stored at
-70°C until, used.

4 ml of cold 3/j acetic acid.

The cellular nucleic acids

were precipitated with 6>o trichloroacetic acid and then
washed with 3 ml of cold PBS pH 7.2.

The filters were dried

for 2 hrs in a 65°C oven and transferred to scintillation
vials (Beckman) which were filled with 3 ml of POPjPOPOP
scintillation flour (Table 7) and counted for 10 rain in a
Nuclear Chicago Unilex III liquid scintillation counter.
The counts of the triplicate samples were averaged to give
one value for each leukocyte sample.

The stimulatory index

(S.I.) was calculated by dividing the counts of the PHA-P
sample by the counts of the control sample.

Table 7

Scintillation flour.

POPOP (1,4-bis 2~(5 phenyloxazolyl) benzene (Sigma) 0.05 g
POP (2,5-diphenyloxasole) (Sigma)

4,0 g

Toluene • . . . . . • . . . • . • • . • • • . . • • 1 liter
Store in brov/n bottle to prevent exposure to light.

Irnmunofluoresconce
Two x 10^ leukocytes tha.t had been obtained vie, ficolldiatrizoate separation were placed in 12 x 75 mm test tubes
and washed twice with PBS pIT 7.2.

After the second wash,

the cell pellets wore resuspended in 0.4 ml of a 1:30
dilution of anti-bovinc globulin serum of rabbit origin
•conjugated with PITC (Colorado Serum Co.).

The cells were

incubated, on ice at room temperature for 45 min and then

washed four times in PBS with 3/$ PCS.

The. leukocytes were

resuspended in 0.25 ml of PBS with 50. '• glycerin and placed
on glass slides under cover slips.

All slides were viewed

using an AKO fluorescence microscope.

A total of 200 leuko

cytes were counted and fluorescent cells were recorded as
B-lyrnphocytes and non-fluorescent cells as T-lymphocytes.

E—rosette Assay
The E-rosette assay was carried out with modification
by the method of Jondal et_ al (25). Leukocytes separated
via ficoll-diatrisoate were resuspended ill Hank's BSS with
/
10/i PCS at a coneentration of 1 x 107 cells/ml.
One tenth ml
of this suspension was added to 0.1 ml of a Vf> suspension of
sheep red blood cells (SRBC).

The cells were gently mixed

and incubated at 37°C for 10 min. Following incubation,
the cells were centrifuged at 200 x g for 5 min and allowed
to sit overnight at 4°C.

The following day the pelleted

cells "/ere gently resuspended by rotating the conical cen
trifuge tube on a horizontal axis until all cells were in
suspension.

The cells were added to o. cold Neubauer hemo-

cytometer and allowed to settle.

Two hundred cells were

counted and the number of rosette forming colls determined.
A cell with three or more 3PJ3C adhering to its surfo.ee was
considered to be a rosette.
Humoral Response to a T-dependent Antigen
To assay for production of antibody to a T-dependent
antigen, all calves received 5.0 ml intravenous injections
27

of a 5.0 mg/ml preparation of human albumin fraction V
(Sigma).

Serum camples were collected on day 0, 7 and 14.

Anti-human albumin antibody was measured by indirect
hemagglutination.
Indirect hemagglutination: Using "U" bottom microtiter
plates (OECO), each test -'/ell in columns 1-12 received 50
of PBS pH 7.2 with 2',o normal rabbit sera (NKS)•

jaI

Fifty p.1 of

whole sera was added to well 1 and titrated out through well
12 using 50 p.l microdiluters.

Ml wells then received 50 jul

of a 0.5';'' suspension of SRBC sensitised with human albumin.
Controls of tanned and sensitised SRBC wore included in the
experiment.

The plates were incubated at room temperature

for 2 hrs and the titers determined.
Sensitization of SRBC's;

A 3/» suspension of SRBC in PBS

pH 7.2 was mixed with an equal volume of a freshly prepared
1:40,000 dilution of tannic acid (Baker) and incubated in a
37°C water bath for 15 min.

After incubation, the SRBC were

washed once in PBS and resuspended in a 3'/j suspension.

The

SRBC suspension was then mixed v/ith an equal volume of a
5.0 mg/ml preparation of human albumin fraction V and in
cubated at room temperature for 15 min.

The SRBC were washed

twice in PBS and resuspended at a concentration of 0.5/$ in
PBS pll 7.2 with 2-1 NRS.

Immunoelec trophoresis
Immunoelectrophoresis was performed using 1^ agarose
(Seakem) in veronal buffer (Table 8) oil a glass microscope
28

slide.

Electrophoretic separation of bovine serum was

carried out at 3 maraps/olide over a 3 hr period, /aiti-bovine
sera (rabbit origin) was added to troughs cut into the agarose
slides and the slides were incubated in a humid chamber at
room temperature for 48 hrs. Evaluation of normal and weak
calf sera was done by comparing the immunoelectrophoretic
pattern (precipitin arc shapes, intensities, general appear
ance and electrophoretic location) of the various sera after
precipitation with anti-bovine sera.

Table 3

Veronal buffer pH 8.4.

0.2 I-.I sodium barbitol (Mallinckrodt Inc.) ..... 50 ml
0.2 LI HC1

S ml

Distilled water

.141 ml

Delayed Hypersensitivity to BCG
The Paris strain of BCG vaccine (43) was obtained from
stock maintained in the Stella, Duncan Institute, University
of Montana., Missoula, Montana.

The initial stock cultures

were diluted in Dubos broth to achieve an optical density of
K-100 on a Klett-Gunmcrson photoelectric colorimeter and
stored as the working solution in vials at -70°C until ready
to use.
All calves were vaccinated with 2.5
via intramuscular injections.

jtiI

of the BCG vaccine

Two weeks after vaccination,

the calves were skin tested in the caudal fold with 800 p.g
of BCG protoplasm.

Skin tests were measured 72 hrs after

being administered.
The BCG protoplasm was obtained from the Stella. Duncan
Institvite and was prepared by resuspending twice-washed BCG
bacilli in distilled water at a concentration of 10-15 g
(net v'eight) of bacilli per 100 ml.

Cells were ruptured in

a Sorval Ribi coll fractionator at 45,000 psi, and the
effluent was centrifuged at 27,000 x g for 1 hr to remove
cellular debris.

The supernate, referred to as BCG proto

plasm, was lypholyscd and stored at -20°C.

Macro phage T:!i gration Inhibition Assay
Production of MIP:

Leukocytes separated via ficoll—

diatrisoate were adjusted to a concentration of 5 x 106
leukocytes/ml in II-192 media with 10;.' PCS (Table 2).

Two

ml of the leukocyte suspension was placed in duplicate tissue
culture tubes.

One tube received 100 ;ug of the BCG skin test

antigen and the control tube received none.

The cultures

were incubated at 37°C for 43 hrs in 57* COg.

After incubation,

the leukocytes were centrifuged at 400 x g for 10 min, and
the supernate fluids containing the MIP were removed.

The

supernates were stored at -70°C until used.
Collection of guinea pig macrophages:

Normal guinea

pigs received intraperitoneal injections of 30 ml of sterile
mineral oil to increase the number of macrophages in the
peritoneal cavity.

Approximately 72 hrs later, the animals

were sacrificed and tacked on an autopsy board.

After the

abdomen was gently kneaded, 50 ml of cold, sterile Hank*s BSS
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with 10 units of preservative-free heparin (Lilly)/ml was
injected into the peritoneal cavity.

An incision was made

into the peritoneal wall, and the fluid withdrawn with a
50 ml syringe and placed in a cold separatory funnel.

Upon

standing, the layers soon separated and the aqueous layer
was decanted into cold, siliconized, 40 ml centrifuge tubes
and were centrifuged at 200 :c g for 10 min at 4°C.

The cells

were collected and washed twice v/ith Hank's BSS without
heparin.

After the final 'wash, the cells were resuspended

to a final concentration of 10';•> by volume in 11—199 media,
containing 1 5£,j guinea pig serum.
HIP assay:

Capillary tubes were filled to 3/4 volume

with the macrophage suspension end one end plugged with warm
paraffin wa".

The capillary tubes were then placed in

sterile tubes 'with cotton plugs on the bottom and centri
fuged a.t 200

g for 5 min to pack the cells.

The capillary

tubes v,rere cut at the interface between the cells, and the
supernate with, a diamond pencil, and the portion with the
cells was attached to the bottom slide in sterile Kackness
chambers with silicon grease.

The Ilackness chambers were

incubated at 37°C for 24 hrs.

The results were recorded by

drawing scale drawings of the migration patterns, and the
percent inhibition was calculated using the following formula:

inhibition -1.0- M L x 100
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Table 5

K-199 media with Earl1s co.lts

II-199 powder (Gibco)

..

9«9 g

Triple distilled water .......... 1 liter
Penicillin G

100,000 units

Streptomycin sulfate

100,000 )xq

IIarIC03 (Baker)

1.5 £

Fetal calf serum (Microbiological Associates)
inactivated at 56 C for 30 rain
100 ml

Processing of Thymus Extract
'Thymosin was extracted from bovine thymus glands by a
modification of the method of Goldstein and YThite (17).
Bovine thymus glands obtained from a local abattoir were
homogenised in Y/aring blenders with 0.35^ NaCl.

The homo-

genate was centrifuged in 250 ml plastic centrifuge bottles
at 3,500 x g for 5 min at 4°C.

The supernatant fluid was

decanted into 500 ml glass flasks and placed in 80°C water
baths for 15 min.

Most of the precipitate wo.s removed by

contrifugation o.t

3,500 x g and then cleared further by

centrifugation at 16,000 rpm for 1 hr in a Sorval high speed
centrifuge.

The clear supernatant fluid was decanted and

precipitated with acetone at 4°C.

Acetone precipitation was

accomplished by adding the clear supernate to 10 volumes of
cold acetone with constant stirring.

The precipitate formed

was placed in on evaporating dish and allowed to sit overnight
in the cold room.

The dried precipitate wo.s resuspended in

0.1 II phosphate buffer pH 7.2 by constant stirring for 3 hrs

and then centrifuged at 3,500 x g for 15 mill.

The oupcrncito

was collcoted by clocanting end then precipitated with
saturated (NIL,)
lr

at room temperature.

c.

The final pre-

Lr

cipitate v.*as resuspended in distilled -water and dialysed
overnight against tv:o changes of distilled water to remove
the (HIL)
•
L\ oSO,.
£. L\-

The suspension was lypholysecl and stored

at —20°C.

Adjqinistration of jlhymus Extracts
Calves numbered 10-15 and 25-23 received 30,000 ug of
thymosin monthly in two intramuscular injections over a
period of four months.

The first injection v;ao administered

in 5.0 ml of PB3 at a concentration of 1,000 jig/ml•

The

second injection was administered in 5.0 nil of a 50;..; PIS0 50;.' peanut oil (Planters) mixture at a concentration of
5,000

thymooin/ml..

Statistical Analysis of .Data
Statistical analysis of the data was done using the
Mann- .'hitr.oy U

The !J test is a nonparr.motric test

tb.Clt i.' i1 r'n 10 " "it 071*2 PJ10 "'he ti'1 OP t' "0 i.'lO-O 031dolit ^POIIPO
:rovi !;hp

hooii

-;o.rulrtion (30)•

n:v-rn fi ornee -i .0 oh hh.pof 1
rri;atiotic
:no

rj

o< 1

cv.lr

.he level of

'si-iv* the v.?luo of the

'I in o'-e '* onnorijaent•
*'1,; "if^ U 'joit, the dc/ba fron the t"'0 f:roupo .opc

combined on-"1 rT1 "O'"7 in orfrr^ of deeper"p n,r* eioc •
ecorc ic roox^r"^ tp-o

1

or -cot po.nh*

fhe lovoot

hie rjup of the p^nhec

scores in each group is calculated and used in the following
formula:
U

=

n^2 +

1).

- R1

or

U = n^n2 + .n2,(n.|

,1l - R

n^ - number of items in the smal3.er group
n2 - number of items in the larger group
R.j = sum of the ranks of the items in the smaller group
R2 = sum of the ranks of the items in the larger group
The smallest value of U is calculated and used to find
the level of significance in the appropriate table (50).
When the statistic is assigned a p value (probability value)
less than 0.05, the tv.-o groups are considered to be signifi
cantly different and axe considered to be tv/o separate

populations.
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Total and Differe 111ia], Leukocyte Values
Comparisons of differential leukocyte values (Table 10)
between normal and weale calves showed
ference.

110

significant dif

AILvalues fell within the range of normal bovine

values .as reported by Schism (47). The average lymphocyte
differential of normal and weak calves were 74.1?^ and 74•2$
respectively.

The average total leukocyte count was found

to be higher in normal calves (7,833 Y/BC/mm^) than in weak
calves (6,609 V/BC/mrr^), but this difference was not found
to be significant (p> 0.05).

Separation of Peripheral Biood Leukocytes
Ficoll-diatrisoate density-gradient centrifugation was
found to be an effective method for the isolation of a
reasonably pure population of mononuclear lymphocytes and
monocytes. The lymphocyte population was found to sediment
at the interface between the ficoll-diatrizoate and the
Hank's BSD while the granulocytes were distributed throughout
the ficoll-diatrisoate, directly above the erythrocyte pellet.
Granulocyte contamination was found to bo less than 5'p as
determined by differential staining of the purified lymphocyte
preparation and lymphocyte viability, measured by trypan blue

Table 10
Number

Total and differential leukocyte valuea of year-old normal and weak calves.

-,'j lymphocytes

?-> monocytes

i .5
1.0
J •J

avs

Lu
o*

a,;Te

7/eak calve;
10
11
13
14
15
1?
17
13
20
22

o^
24
25
27
average

r\

1. 0

.0
ou.p
74.1

5.5
4.5
^ O

.0
74.0
74
71.5
71 • >
53
53.9
•5
54•5
64.5
84
84.5
•5
61.0
61•
80•5
30.5
.0
84.0
84
80 • o
30.5
71.5
71
81.0
81.0
76.0
76
•9
82
82.5
o
74.2
74

6.9
5.0
2.0
2*0
1.0
1.0
3.5
2.5
0.5
2.0
2.0
2.5
1.5

rs

•D

*5 R

J.-x

1.5
4.5
2.8

'J
'/'eosinophils
x
segmented -juvenile
18.0

-j O -r
3J.5
3.0
15.0
9.0
13.0
17.3
13.0
14.0
23.5
22.5
5.0
24.5
14.5
11.0
1 1 .13
11.9
13.5
11.0
16.5
9.0
14.6

1.0
0.5
1.0
0.5
1.5
3.0
1.3

j.J
3.5
0.5
4.0
1.5
7.0
2.0

1.0
1.5
4.0
3.5
2.9
1•

2.7

Total V/BC/mmJ

4.0
1.0
1.5
1.5
2.5

5,62d
5,025
3,000
G OP°
JC
c, 400
11,158
7,833

j.5
5.0
15.^
7.0
5.5
5.0
2.5r
O ~*
4.0
9.5

5,475
5,025
5,300
6,200
6,500
6,650
7,660
5,425
6,213
,425
10,125
,jO
6,100
6,609

1.0

3.5
2.5
5.2

s )

exclusion, was grea/fcer than 99%

The ptirified lymphocyte

preparation was used in all subse.qtient in vitro assays.
Occasional difficulties arose in the separation of PBL when
agglutination of buffy coat layers occurred.

These samples

were discarded and new blood samples obtained end processed
whenever possible.

."Determination of Lymphocyte Subpopulatioils
Lymphocytes were divided into two major subpopulations
based on immunofluorescence after incubation with PITC
conjugated anti-bovine globulin serum (Colorado Serum Co.).
No difference was observed between normal calves and weak
calves in the percentage of B-lymphocytes (fluorescent cells)
and T-lymphocytes (lion-fluorescent cells) within the total
population of lymphocytes (Table 11).

Y-.'eak calves were found

to have 31.9/^ B-lymphocytes and 69.1^ T-lymphocytes whereas
normal calves had 33.0^ B-lymphocytes and 67.0/3 T-lymphocytes.
A further division of the population of T-lymphocytes
was made using the E-rosette assay.

This subpopulation of

T-lymphocytes was also found to be consistent in both groups.
The population of rosette forming colls (PJ?C) was 14.9/^ in
normal calves and 15.2,in weak calves.

B1astogenosis
Lymphocyte stimulation bj/ PHA-P 'was observed in both
normal calves and weak calves.

The results of the blasto-

genesis study are shown in Table 1?.
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Although weak calves

Table 11

Number

Lymphocyte subpopulations present in peripheral
blood of normal and weak calves.
Iv-rosettes

B-lymphocyte:

Normal calvej
3.0
5.5

19

2.0

21

7.0
3.5
5.5
4..Q

^ .i 9
33.0
36.5
34.0
26.5
34, 5
33.0

12.5
13.5
13.0
16.0
18.0
14.5
10.0
14.0
16.5
14.5

28.0
27.5
35.0
35.0
30.5
34.0
29.5
36.5
32.0
34.5

12
16

26
28
average
Weak Calves
10
11
13
14
15
17
18
20
22
23

67.5
67.0
63.5

72.0
72.5
65.0
65.0
69.5
66.0
70.5
63.5
68.0
65.5

66.0

72.5
65.5
67.0

24

16.0

28.0

72.0

25

18.0

34.0

66.0

27

average

13.0

30.0

70.0

1^.2

31.9

68.1

1O
JO

Table 12

Bias"togenie response of normal and weak calf
peripheral blood lymphocytes after stimulation
" •

•, _L L>ll

Number

-pi.T A

J- iiii—1 •

Control, cpm

PHA-P cpin

S.I."

Normal calves
1,711.9
12
16
918.5
1,074.8
19
21
1,444.6
26
1,273.8
28
2,134.5
average
1.426.4

37
13
78
36
14
89
45

324.4
968.5
652.9
180.4
449.0
012.2
014.6

22.1
15.2
73.2
25.0
11.3
41.7
31.4

Y/eak calves
10
11
13
14
15
17
18
20
22
23
24
25
27
average

8
11
78
84
25
55
64
81
74
54
11
68
73
53

078.4
609.0
340.5
006.7
839.0
741.0
055.4
988.0
730.0
062.6
166.3
502.0
295.9
248.1

9.9
6.2
72.1
44.1
16.4
75.3
52.5
60.6
43.3
38.7
7.3
39.0
44.1
39.2

816.2
1 ,870.5
1 ,005.9
1 ,924.5
1 ,577.8
739.8
1 ,219.4
1 ,352.9
1 ,727.7
1 ,398.7
1 ,532.0
1 ,756.4
1 ,663.6
1 ,435.8

"^Stimulatory inde:c (S.I.) = PHA-P cpm/Control cpm.

had an. overall higher rate of tritiated thymidine incorpor
ation than normal calves as indicated by the higher average
stimulatory index (S. !•), this wa.s not found to bo significant
(p <0.05)•

The average S.I. of normal calves was 31.4 with

S.I. values ranging from 11.3 to 73.2.

The average S.I. of

weak calvos vas 35.2 ;"ith S.I. values ranging from 6.2 to 75.3.
Humoral Rcponse to a T-dependent Antigen
A humoral response to human albumin fraction V, a
T-dependent antigen was observed in both weak calves end
normal calves.

Bay 14 antibody titers, measured by hemag

glutination ranged from 1:16 to 1:28 in weak calves end from
1:8 to 1:64 in normal calves.

No difference in the ability

of normal and weak calves to respond to human albumin fraction
V v -as observc d.
Inmunoelectrophoresis
Since the only bovine anti-sera available was anti-whole
bovine sera (rabbit origin), comparative Immunoelectrophoresis
was done rather than quantitative Immunoelectrophoresis.
Evaluation of normal and woak calf sera was done by comparing
the immunoelectrophoretic patterns of the various sera after
precipitation by anti-whole bovine serum.
The results of the imnLinoolectrophoresis study showed
no discernible differences in the electrophoretic patterns
of normal and weak calves (Illustration 2).

No precipitin

arcs observed in normal calf patterns were absent in the pat
terns of weak calvos and no additional arcs wore present either.
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Table 13

Humoral response to human albumin, a T~dependent
o.ntigen, in normal and vreak calves.
Number

Day 0

Day 7

Normal calve".:
12
<1:4
16
1 :4
19
1:4
21
< 1 :4
26
<1:4
oO
O
1:4

1
1
1
1
1
1

V/eal: calves
10
1 :4
<
1 :4
11
<
1
13
:4
1 :4
14
< 1 :4
15
1 :4
17
,i
13
1 ••'r
20
< 1 :4
^ 1 :4
9
<1 :4
<1.A
24
<1:4
<1 :4
27

1 :32
1 • 3) O
1•
1:1 6
1:32
1 :32
r* o
1 .• J'
1 :32
1 164
1 :16
1:16
1 :32
1:32

i... el

r> ;~~
c-: )

16
16
16
16
16

Day 14
1:16
1:64
1:32
1:32
1 :3
1 :16
1:32
11.
• 70
J>
1:16
1:16
1 :32
1:64
1 :32
1 :1 23
1 :64
1:16
1 :32
1 :32
1 i j2

Illustration 2. Sample irnmimoelcctrophorotic patterns
normal calves (#21 and 28) and v/eak calves

17 and 22)

21

28

17

22

Dolayed Hypcrs elisitivity t o BCG
All c0-1vco immunised with the BCG vaccine were found to
"be capable of mounting a delayed hypersensitivity response
when injected with 0.2 ml of the BCG skin test antigen
(BCG protoplasm).

Skin tests were administered in the caudal

fold two weeks after immimi:;;ation v;itli the BCG vaccine, and
the area of induration was measured 72 hrs after the in
jection was given. 'The results of the skin tests are given
in Table 14.

A positive delayed hypersensitivity response

is normally considered to be indicated when the area of
induration is 3 mm or greater at the test site 24 hrs after
injection of the skin test antigen (51). 'The 72 lir time
period was used in this study since the responses 'were
greater than the 43 hr responses and this permitted better
resolution "between the various responses.
The data in Table 14 indicates that, whereas both normal
and weak calves -•ere ce.pa.blc of mounting positive delayed
tuberculin hypersensitivity responses, the area of induration
was significantly greater in normal calves (p < 0.001).

Thymosin Therapy
Thymosin therapy in 10 of the 19 calves (3 normal and
7 weak calves) consisted of monthly injections of 30,000 j.ig
of thymosin.

The remaining 9 calves (3 normal and 6 weak

calves) served as controls and recoived no thymosin or
placebo.

During the course of thymosin therapy, no outward

physical changes or improvements were noted in weak calves

Table 14

Delayed tuberculin responses in normal and weak
calves sensitised v/itli 3CG-.

Number

Delayed Hypersensitivity Response in cm,

Normal calves
12
16

2.0

:

19

2.0

x

21

1.5

-

2.0

26
28

2.0
2.0

x
x

2.0
2.5

2.0
0.75
1.0
1.0
0.75
1.5
1.25
1.5
1.5
1.0
1.5
1.0
2.0

x
::
x
x
x
x
x
x
x
x
x
x
x

1.5
0.5
1.0
' 1.0
1.0
1.5
1.25
1.0
1.5
1.5
2.0
1.5
2.0

.Veal: calves
10
11
13
14
15
17
13
20
22

23
24
25
27
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o ^
2.0

treated with thymosin that were observed in the controls.
General improvement in the outward appearance of the weak
calves, such as hair coat texture and periorbital edema,
were noticed in all calves during the course of this study
but was not confined to those weak calves receiving thymosin.
'The weights of all calves were recorded at the commence
ment of thymosin therapy and arc tabulated in Table 15.

The

initial average weight of the normal calves was 546 lbs
compared to 350 lbs for the weale calves.

After three months

of thymosin therapy the calves were reweighed.

The average

weight of the normal calves had increased to 682 lbs and the
average weight of the weak calves had increased to 500 lbs.
The percent weight increase of the weak calves during the
three months was found to be significantly greater than that
of the normal calves (p< 0.001), but the overall weight
increase was not.

Comparisons of the thymosin treated and

control weak calves as well as thymosin treated and control
normal calves showed no difference in the percent weight
gained or the net weight gained.
Ee-evs,luation of delayed tuberculin hypersensitivity
of thymosin treated and control animals "was conducted after
each month of thymosin therapy.
Table 16.

The results are given in

In those calves receiving the thymus extract,

no significant difference was observed in the ability of
normal and weak calves to respond to the skin test antigen.
In two of the three re-evaluations conducted in control
animals, normal calves e:diibited a significantly greater
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Table 15

A comparison of tlie weights of normal and weak
calves before and after thymosin therapy.
J'ov'-x-

Number

-,r<~

A Y/eight

Y/t.IncreclSG

Normal calves - thymosin treated
625
12
510
26
400
455
28
640
775
700
average1*
573

115
55
135
125

22.5
13.7
21.5
21.7

Normal calves - controls
16
520
1Q
40-3
21
535
average
517

130
140
120
147

34.6
OO J
22.4
23.4

Y/eal-: Calves - thymosin treated
10
450
570
270
390
11
13
335
490
14
305
455
455
640
15
420
550
25
495
27
345
avert
368
513

120
120
155
150
1 09
130
150
145

26.7
44.4
46.3
49.2

•Veal: calves - controls
17
305
18
315
20
335
22
315
O *"»
350
*0
330
24
average

120
175
145
185
165
140
155

39.3
55.5
43.3
58.7
47.1

700

635
66

425
490
500
515
520
488

A O <~

40.6

43.5
42.4
39.4

36.8

46.5

*

V;eight -;'-1 represents the weight of the calves o,s of
7/27/77. The day on which thymosin treatment began.

**

weight v'2 represents the weight of the calves as of
10/24/77. All thymosin treated calves had received
three monthly treatments with thymosin by this date.

t

The average of the normal calves treated v.dtii thymosin
does not include data from calf ;i'26. Calf 25 became ill
shortly before thymosin treatment and lost consider,able
weight but was carried through the experiment with the
other calves.
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Table 16

Nuraber

Delayed tuberculin responses in normal and weak
calves during thymosin t!iera.py.
Test A'"'

-V..v.
Test B'"""r

Test C<x"'f"

Control calves
Normal c alves
16

2.0

2.0

19

1 .25
0.75

1.25
0.75

21

',7oak calver.
0.75
17
0.5
13
0.25
20
22
1 .5
0.25
23
0.5
24

x
x
x
x
x

0.75
0.5
0.25
1.0
0.25
X 0.5

P.O
0.5
1.0

2.0

1.5

1.5

0.5
1.0

1.0

1.0

1.5 x 1.5

0.5
0.25
1 .0
1.5
1.0
0.25

x 0.5
X 0.25
x 1 .0
1'Z 1.25
X 1.0
X 0.25

N.n.
N.R.
0.25 x 0.25
0.75 x 0.75
N.E.
0.25 x 0.25

1.0
0.5
2.0

x 1 .0
x 0.5
x 2.0

1.0
1.0
1.5

thymosin treated calves
ITormal c alves
12
0.75 x 0.75
26
1.0 x 1.0
23
1.5 x 1.5
eak calves
1.25 x 1.25
10
0.5 x 0.5
11
1.5 ;
: 1.5
13
0.75 x 0.75
14
1.3 x 1.5
15
O n;
1.25 x 1.25
1.5 x 1.5
27

**
***

1.0 :£ 1.0
N.I
1.5 •i'l.O
1 .25 -i 0.25
0.5 :•: 0.5
1 ,2'j ::: 1.25
1 .0 ::: 1.0

Test A - 8/20/77 skin tost
Test 13 - 9/23/77 skin test
Test C - 10/24/77 skin tost

IT.II. = no reaction
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1.0
x 0.5
x 2.0

0.5 x 0.5
0.5 x 0.5
0.75 x 0.75
IT.E.
1.0 x 1.0
0.75 x 0.75
1.5 x 1.0

capacity to respond to the skin test antigen (p < 0,05).
The significance of the difference in the normal and weak
calf controls to respond to the skin test antigen was not
found to be as great .as that observed in the initial delayed
tuberculin hypersensitivity tests (p< 0.001).

It should be

noted that large fluctuations were observed in the delayed
hypersensitivity responses of individual animals (both
normal and weak calves) from test to test.
An in vitro macrophage migration inhibition assay was
performed to evaluate the in vitro sensitivity of normal and
weak calf lymphocytes to the BCG skin test antigen.

The

inhibition of guinea pig macrophages was assayed by indirect
I.1IF tests using supomates from bovine lymphocyte cultures
incubated with and without the skin test antigen.

All super-

nates tested displayed positive inhibition of macrophage
migration (Table 17).

A 0.80 migration index (20^ inhibition)

is normally interpreted as a positive response (21). No
differences were noted -when comparing the average migration
indices of normal calf controls (0.70) to cither weak coif
controls (0.67) or to normal calves that had received the
thymus extract (0.67) or when comparing weak calf controls
(0.67) to weak calves that huad received the thymus extract
(0.65).

The migration indices of normal and weak calves did

not show any significant differences when compared as did the
initial skin tests.

Table 17

Inhibition of macrophage migration by HIP produced
by lymphocytes from normal and weak calves
sensitized with BCG.

Number

I Migration Inde:c"'T

y> Inhibition

Control calves
Normal calves
16
19

0.60
0.59

21

average
Weak calves
17
1O
20
22

2 jj
24
average

31
41

0.74

26

0.67

33

0.72

23

0.74
0.62

26
38

,

0.61
0.67

39
33

Normal calves
12
26
23
average

0.70
0.65
0.72
0.70

30
35
28
30

V.'eak calves
10
11
13
14
15
25
27
average

0.43
0.64
1.62
0.76
0.57
0.66
0.79
0.65

52
36
33
24
43
34
21
35

thymosin tree-ted calves

I'!ir:rati on Index

area of mlgration with antigen
area of migration without antigen

Contamination of these chambers prevented the calculation
of the ','j macrophage migration inhibition for these samples
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The Effect of Thymosinon E-rosotte Formation
The in vivo and in vitro effects of thymosin on
E-rosette formation of peripheral blood lymphocytes of
normal and 'weak calves were examined. PBL separated from
blood samples of thymosin treated and control animals were
assayed for E-rosette formation ih the absence a.nd in the
presence of thymosin (100 jig/ml)•

These results are tabulated

in Table 18.
No increase in the percentage of the RFC population
present in P31 v:as observed in normal and weak calves that
had received thymosin therapy when compared to control calf
values or their ov/n pre-thymosin values. In vitro incubation
of PBL with thymosin also resulted in no significant increase
in the percentage of RFC.
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Table 13

E-rosette formation of peripheral blood lymphocytes
of normal and weak calves after in vivo thymosin
therapy and in vitro incubation with''thymosin.

Number

pre—thymosin

post-thymosin

in vitro thymosin

Control calves
Normal calves
16
13.5
12.0
15

13.0

19.0

18.0

16.5
15.0
16.3

17.0

14.5

average

14.8

15.8

/oak calve
17
18

14.5
18.0

15.0
14.0
16.5

21

20

14.0

22

16.o
14.5
16.0
15.7

23
24
average

13.0
14.0

15.5
15.5
17.0
13.5
16.0

17.5
15.0

19.5
17.1

17.0

18.0

14.5
14.0
15.2

12.5

Thymosin treated calves
Normal calves
12
26

28
average

15.0
13.5
16.5
15.0

19.0

17.5

".Veak calve;
10
11

13
14
15
25
27
average

12.5
13.5
13.0
16.0

18.0
13.0
13.0

14.9

1 3.0
15.5
15.0
12.0
13.5
1 <->.j
14.5
14.6

1 2.5
19.0

16.0
14.5
17.5
20.0

12.5
16.5

Chapter 4
DISCUSSION
V/'hile a specific etiologic agent of the Weak Calf
Syndrome has yet to "be ascertained, evidence available sug
gests that the syndrome is the result of an infectious pro
cess.

After recognition of the syndrome as a possible new

dises.se entity of neonatal cattle in 19.64, inquiries at
several ranches in the Bitterroot Valley revealed that
once the disease was experienced in a herd, the problem
became enzootic, occurring each year with a varied incidence.
The disease was particularly evident eraong ranches operating
an open herd and routinely bringing in replacement heifers.
Ranches -with a closed herd did not appear to suffer these
losses.
An inspection of herd management records from ranches
with the V;'eak Calf problem revealed that dams appeared to
abort or give birth to weale calves only once (61) suggesting
that the dams develop an immunity to the disea.se.

The

apparent immunity prompted the treatment of afflicted calves
by transfusions with whole blood obtained from selected dams.
V/hile this approach appeared to have a beneficial therapeutic
value, the favorable response was short lived.

Since the

administration latere of cell-free scrum from the same

.selected dams v:as reported to be much more effective a.s a
long term benefit, the outcome of a graft—versus-host
reaction has been suspected in severely afflicted celves
receiving the complete cellular components.
A comparative study between animals surviving the
disease condition and normal calves of comparable ages show
weak calves to be considerably smaller than their counter
parts and appear to exhibit varying degrees of a "wasting
disease."

The condition is similar to the runting and

wasting observed in laboratory mice after neonatal thymectomy
(313) and other forms of stress (5,54).

The calves demon

strating this "wasting" are characterized by a runted
appearance, periorbital edema and a rough coat which becomes
dull, shaggy and matted as the disease progresses. In view
of the thymic atrophy observed at necropsy in severely
afflicted calves sue climbing to the disease, the runted
condition of these calves was assumed to be related to
the thymus.
The possibility of immuneincompetence occurring ill wealc
calves is suggested by the depressed lymphocyte proliferation,
as measured by the standard blastogenic response to PHA
in vitro, in newborn calves (64) as well as by the inability
of weak calves to mount delayed hypersensitivity responses
to tuberculin skin test antigens after appropriate sensiti
zation (56).

The depression in the immune response prompted

earlier studies with thymosin, a protein thymic extract

shown capable of restoring immunocompetcnce and reducing
the incidoncG of wasting in neonatally thymectomiscd mice
(1,17).

The regimen of thymosin therapy used in the treat

ment of newborn weak calves resulted in an improvement in
their clinical appearance and general health but was not
long lasting (64), probably due to the short duration of
the treatment.
Because of the problem the V/eak Golf Syndrome repre
sents to the cattle ranchor, this study was designed to
evaluate the treatment of weak calves with thymosin over a
longer period of time in an attempt to correct the "runting"
associated with the disease. In order to monitor the immune
status of the weak calf during and after thymosin therapy,
an assessment of several immune parameters was conducted
prior to thymosin therapy.
The assessment of the immune status of the weak calf
indicates that while weak calves are afflicted with a runting
syndrome, these animals do not possess gross immunologic
abnormalities.

Except for a depression in delayed tuberculin

hypersensitivity, no significant differences were noted in
either the population of circulating lymphocytes or the in
vitro measurement of cellular immune responsiveness.

The

immunologic depression reported in newborn weale calves was
not observed in those weak calves surviving the initial year.
These calves appear to have overcome the immunosuppressing
factor(s).

During the period of time that separates the

two groups of '--oak calvcs in age, a return to normal immunologic
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responsiveness, with the exception of delayed hypersensitivity,
has occurred.
Using delayed tuberculin hypersensitivity to monitor
immune responsiveness in the weak calf, thymosin was
administered to both normal and weak" calves for a period of
three months.

During this time '/eight gain as veil as

delayed tuberculin hypersensitivity was monitored in thymosin
treated and control groups of norms,! and weak calves.
At the conclusion of thymosin therapy, no disccrnable
effects of trcatr.iont with the thymic extract were noted in
the v/eak calves1 general appearance or in their ability to
attain normal weight.

It was noted, however, that the

general appearance of v/eak calves did improve during this
time regardless of v/hether they received thymosin or not.
Also, comparative "/eights of the v/eak calves to normal calves
increased from 64/' to 74^ suggesting that the initial effects
of the V;eak Calf Syndrome resulting in the runted appearance
may be overcome to some degree given sufficient time.
The effect of thymosin therapy on delayed hypersensi
tivity in year-old v/eak calves appears inconclusive at this
point.

V/'hile the significant difference that did exist

between the two groups prior to treatment with, the thymus
extract disappeared in thymosin treated calves, the decreased
statistical difference observed in control animals and the
inconsistencies in responses of individual animals make
interpretation of the data difficult.

Possible explanations

for these inconsistencies are that the sensitization with

the BCG vaccine ' as inadequate to achieve a lasting cutaneous
delayed hypersensitivity or that delayed hypersensitivity
may not bo an effective method for measuring cellular immune
responsiveness in cattle.

In order to elicit a delayed

tuberculin response, 309 ug of the skin test antigen is
required to elicit a response in contrast to the maximum
5 ug dosage used in man.

The ability to mount constant

and uniform delayed hypersensitivity responses may thus
not be a suitable testing parameter of the bovine immune
system.
The ability of thymosin to increase the number of
rosette forming cells (RFC) in peripheral blood lymphocytes
(PBL) obtained from patients with immunological deficiency
diseases after in vitro incubation with thymosin and after
in vivo thymosin therapy has been reported in the literature
(59,60)•

These patients include those with primary cell-

mediated immunodeficiencies, thymic hypoplasia, acute systemic
lupus erythematosus and certain cancer patients.

In vitro

incubation of PBL with thymosin has been shown to be useful
in identifying irnnunodeficiency patients who may be candi
dates for in vivo thymosin therapy (50).
In this study, no increase in the number of HFC .could
be attributed to thymosin treatment, either in vivo or in
vitro.

The percentage of i!?C in "^BL of normal and weak

calves before and after thymosin treatment and after in vitro
incubation • 1th thymosin remained relatively unchanged.
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The inability of thymocin to affect any changes in the
percentage of HFC

in -"oak calf peripheral blood or the grow

ancl appearance of year-old -/oak calves indicates that the
regimen of thymosin therapy used here had no apparent bene
ficial effect.
In order to assess fully the therapeutic ability of
thymosin, additional studies appear warranted.

These -studio

should include a longer period of thymosin therapy and a
higher concentration of the thymic extract.

Because of the

rapid improvement reported in young calves treated with
thymosin, it seems probable that the results of thymosin
therapy are due to an effect other than en increase in
immunological responsiveness.

The possibility of thymosin

.acting in hormonal regulation must also be investigated.
The common cmbryological origin of the thymus, thyroid
and parathyroid glands suggest that the impairment of these
and other glands may also occur.

Thyroidectomised animals

fail to exhibit normal growth and are characteristically
smaller than normal animals (11). I'lanifestations of hypo
thyroidism largely depend 011 the age and extent to which the
deficiency develops.

As age progresses, delayed growth and

development are seen.

Ea.rly treatment with thyroid therapy

in hypothyroid .animals can restore normal growth and
development.
The exact mechanism by which thymosin therapy has pro
duced beneficial results in younger weak calves is unknown,
O
9r~0

"but interrelationships} "between thymosin and endocrine
hormones appear likely.

If thymosin plays some role in

hormonal regulation of the growth processes, thymosin
treatment of older veak calves may "be ineffective since
the;/- have already attained the majority of their adult
growth and development.

Additional studies should then

"be concentrated on younger calves and the prevention of
the associated "runting" rather than trying to correct
the effects of the disease in older calves.
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Chapter i>
ouh;AHY
An assessment of the irnnunological status of the yearold weak ealf '"as conducted using in vivo and in vitro
assays. V.'ith normal calf data serving as ba.seline values,
no immunologic abnormalities or deficiencies, with the
exception of a depressed cutaneous delayed tuberculin hyper
sensitivity, were observed in the v/eak calf.
An examination of the total and differential leukocyte
values as well as lymphocyte subpopulatioiis present in
X-ieripheral blood showed 110 abnormalities in the number of
circulating lymphocytes to exist in v/eak calves.

All data

fell within the accepted range of normal bovine values (57)•
Responses indicating normal immunological responsiveness
were observed in weak calves in studies of in vitro lympho
cyte proliferation, in vitro lymphocyte production of
lyrapholcines and in vivo humoral responses to thyinus-dependent
antigens.
The in vivo measurement of delayed tuberculin hyper
sensitivity showed weak calves to have a, depressed ability
to respond to the BCG skin test antigen.

Since lymphocyte

production of the lymphokiiie I.1P appears to be normal, it
is possible that this depression in delayed tuberculin hyper
sensitivity was due to depressed macrophage function or
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a depression in the ability to mount non-specific inflamraato
responses.
Previous studies which describe depression of cellular
responsiveness in yoking we ale calves, as characterised by
depressed lymphocyte proliferative responses (64) and the
inability of • "eak calves to respond to the BCG skin test
antigen, even after repeated sensitization with the BCG
vaccine (56), were not observed in this study.

These con

trasting observations majr be due to the age difference
between the two groups of experimental animals.

During the

time that separates the two groups in age, a return to norma
immunological responsiveness appears to have taken place.
Thymosin therapy, which proved beneficial to newborn
and 1-2 month old calves (64) was also examined in year-old
calves.

The regimen of thymosin therapy used consisted of

two monthly injections of thymosin, the first (5,000 jag)
administered in saline and the second (25,000 jig) adminis
tered in a 50/ saline and 50^ peanut oil emulsion.
During and after thymosin therapy., a reevaluation of
delayed tuberculin hypersensitivity was conducted.

The

significantly lower responses initially observed in v/eak
calves .va,s not seen in \,eak calves receiving thymosin.
To attribute this change to thymosin would be premature at
this point because of the inconsistencies observed during
the repeated- skin testing in both control and experimental
animals.
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,-eight gain and general appearance of weak calves was
also monitored during thymosin therapy and no improvement
was observed in calves receiving the thymus extract that
was not observed in control animals.

The beneficial

therapeutic activity observed in nc; born and 1-2 month old
weak calves may in some way be due to the endocrine in
volvement of 'thymosin.

Because of the age of the calves

used in this study, these calves may have passed the age
where correction of endocrine imbalances may be effective
in "oromotinT normal growth.
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